News

WFSU News30m
Drugmaker Novo Nordisk slashes Wegovy sales forecasts, blaming compounding
Compounding pharmacies are crimping sales of Novo Nordisk's obesity drug Wegovy by making what are essentially copies of the ...
Weight-loss patients taking Zepbound forced to switch to Wegovy after drop in coverage
Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...
Fierce Pharma5d
Viatris beats Novo in semaglutide patent feud, clearing hurdle for potential Wegovy generic
After inking a related patent settlement last year, Viatris has cleared another obstacle in its quest to launch generic ...
The Patients Forced to Switch From Zepbound to Wegovy
Some patients reluctantly shifted to save money while others have appealed for coverage of Zepbound after having experienced ...
Ozempic And Wegovy Maker Cuts Outlook In Surprise Move, Picks New CEO
Novo Nordisk lowers 2025 guidance as Wegovy and Ozempic face slower U.S. uptake, competition, and continued compounded GLP-1 sales.
Is your Wegovy real? Here’s how to ID fake weight loss drugs
GoodRx reports on identifying real Wegovy pens, which come in five colors and lack dose selectors. Counterfeits pose health ...
Novo Nordisk shares fall 20% after company names new CEO and lowers its financial outlook
Novo Nordisk said it expects weaker sales growth of its popular weight-loss drug Wegovy due to competition from copycat drugs ...
Devdiscourse10h
A New Era at Novo Nordisk: Leadership Change and Market Challenges
Novo Nordisk announces a leadership transition as Lars Fruergaard Jørgensen welcomes new CEO Doug Doustdar. Doustdar aims to ...